Ondansetron Slightly Prolongs QTc Interval in Pediatrics Without Dysrhythmia Risk

This meta-analysis evaluated the impact of low-dose ondansetron on electrocardiographic changes in healthy pediatric patients. The analysis included four studies with a total of 231 participants, predominantly male, aged 0.6 to 18 years. Ondansetron was administered either intravenously or orally, with doses ranging from 0.1 to 0.2 mg/kg for IV and a mean of 0.18 mg/kg for oral administration, not exceeding 8 mg. The primary endpoint was the mean change in the corrected QT interval (QTc), which showed a statistically significant increase of 4.7 ms (95% CI 1.4-8.1). Secondary endpoints included the mean change in the Tp-e interval, which increased by 7.7 ms (95% CI 2.0-13.5), and the incidence of significant QTc prolongation, which was 2.5% (95% CI -0.009-0.059). Importantly, no cardiac dysrhythmias were observed in any of the studies. These findings suggest that while ondansetron administration is associated with a slight prolongation of the QTc and Tp-e intervals, it does not increase the risk of cardiac dysrhythmias in healthy pediatric patients. Clinicians can consider these results reassuring when prescribing low-dose ondansetron in this population, although continued monitoring of QTc intervals may be prudent.

This study focuses on the use of ondansetron, a medicine often given to help with nausea and vomiting in children. Researchers wanted to see if this medication caused any changes in heart rhythms in healthy kids. They reviewed four studies involving 231 children who received low doses of ondansetron. The results showed that there were slight increases in certain heart measurements after taking the medicine, but importantly, none of the children experienced any heart rhythm problems. This suggests that using low doses of ondansetron is safe for healthy pediatric patients and does not raise the risk of heart issues. However, it's important to remember that this study only looked at healthy children, so more research may be needed for those with existing health conditions. Overall, parents can feel reassured that ondansetron is safe for their children when used as directed.